EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds

Hoi Kit Matthew Leung iD, Emily Kwun Kwan Lo iD, Fangfei Zhang, Felicianna iD, Marsena Jasiel Ismaiah, Congjia Chen iD, Hani El-Nezami iD

International Journal of Molecular Sciences · 08.06.2024 · 25 (12) · 6348

DOI: 10.3390/ijms25126348 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.06.2024. Verfasst von Hoi Kit Matthew Leung und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, University of Hong Kong, Pokfulam, Hong Kong SAR 999077, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Tea, Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 221 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancers are causing millions of deaths and leaving a huge clinical and economic burden. High costs of cancer drugs are limiting their access to the growing number of cancer cases. The development of more affordable alternative therapy could reach more patients. As gut microbiota plays a significant role in the development and treatment of cancer, microbiome-targeted therapy has gained more attention in recent years. Dietary and natural compounds can modulate gut microbiota composition while providing broader and more accessible access to medicine. Tea compounds have been shown to have anti-cancer properties as well as modulate the gut microbiota and their related metabolites. However, there is no comprehensive review that focuses on the gut modulatory effects of tea compounds and their impact on reshaping the metabolic profiles, particularly in cancer models. In this review, the effects of different tea compounds on gut microbiota in cancer settings are discussed. Furthermore, the relationship between these modulated bacteria and their related metabolites, along with the mechanisms of how these changes led to cancer intervention are summarized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeTeaNeoplasmsHumansAnimalsBiomarkersPlant Extracts

Stichwörter der Autor:innen

cancergut microbiotametabolitesmicrobiome targeted therapytea compounds

Substanzen

TeaBiomarkersPlant Extracts

Autor:innen und Institutionen

  • School of Biological Sciences, University of Hong Kong, Pokfulam, Hong Kong SAR 999077, China.
  • Institute of Public Health and Clinical Nutrition, School of Medicine, University of Eastern Finland, FI-70211 Kuopio, Finland.

ORCID-Profile: Hoi Kit Matthew Leung, Emily Kwun Kwan Lo, Felicianna, Congjia Chen, Hani El-Nezami

Zitieren

APA

Leung, H. K. M., Lo, E. K. K., Zhang, F., Felicianna, Ismaiah, M. J., Chen, C., & El-Nezami, H. (2024). Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds. International Journal of Molecular Sciences, 25(12), 6348. https://doi.org/10.3390/ijms25126348

Vancouver

Leung HKM, Lo EKK, Zhang F, Felicianna, Ismaiah MJ, Chen C, et al. Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds. International Journal of Molecular Sciences. 2024;25(12):6348. doi:10.3390/ijms25126348

BibTeX
@article{Leung2024,
  author = {Leung, Hoi Kit Matthew and Lo, Emily Kwun Kwan and Zhang, Fangfei and Felicianna and Ismaiah, Marsena Jasiel and Chen, Congjia and El-Nezami, Hani},
  title = {Modulation of Gut Microbial Biomarkers and Metabolites in Cancer Management by Tea Compounds},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {6348},
  doi = {10.3390/ijms25126348}
}
Kostenlos starten →